These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26377157)

  • 1. Bombesin-conjugated nanoparticles improve the cytotoxic efficacy of docetaxel against gastrin-releasing but androgen-independent prostate cancer.
    Kulhari H; Pooja D; Singh MK; Kuncha M; Adams DJ; Sistla R
    Nanomedicine (Lond); 2015; 10(18):2847-59. PubMed ID: 26377157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine conjugated lipidic nanoparticles for enhanced tumor targeting.
    Swami R; Singh I; Jeengar MK; Naidu VG; Khan W; Sistla R
    Int J Pharm; 2015; 486(1-2):287-96. PubMed ID: 25839415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and in vitro/in vivo antitumor efficacy of aptamer-targeted Ecoflex
    Ghassami E; Varshosaz J; Jahanian-Najafabadi A; Minaiyan M; Rajabi P; Hayati E
    Int J Nanomedicine; 2018; 13():493-504. PubMed ID: 29416331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aptamer-mediated delivery of docetaxel to prostate cancer through polymeric nanoparticles for enhancement of antitumor efficacy.
    Chen Z; Tai Z; Gu F; Hu C; Zhu Q; Gao S
    Eur J Pharm Biopharm; 2016 Oct; 107():130-41. PubMed ID: 27393562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peptide conjugated polymeric nanoparticles as a carrier for targeted delivery of docetaxel.
    Kulhari H; Pooja D; Shrivastava S; V G M N; Sistla R
    Colloids Surf B Biointerfaces; 2014 May; 117():166-73. PubMed ID: 24632389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancer.
    Yan J; Wang Y; Jia Y; Liu S; Tian C; Pan W; Liu X; Wang H
    Biomed Pharmacother; 2017 Apr; 88():374-383. PubMed ID: 28122302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective photothermal chemotherapy with docetaxel-loaded gold nanospheres in advanced prostate cancer.
    Shen Y; Ma Z; Chen F; Dong Q; Hu Q; Bai L; Chen J
    J Drug Target; 2015; 23(6):568-76. PubMed ID: 25738990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation, characterization, and antitumor activities of folate-decorated docetaxel-loaded human serum albumin nanoparticles.
    Jiang S; Gong X; Zhao X; Zu Y
    Drug Deliv; 2015 Feb; 22(2):206-13. PubMed ID: 24471890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docetaxel-loaded solid lipid nanoparticles: preparation, characterization, in vitro, and in vivo evaluations.
    Mosallaei N; Jaafari MR; Hanafi-Bojd MY; Golmohammadzadeh S; Malaekeh-Nikouei B
    J Pharm Sci; 2013 Jun; 102(6):1994-2004. PubMed ID: 23558514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docetaxel loaded oleic acid-coated hydroxyapatite nanoparticles enhance the docetaxel-induced apoptosis through activation of caspase-2 in androgen independent prostate cancer cells.
    Luo Y; Ling Y; Guo W; Pang J; Liu W; Fang Y; Wen X; Wei K; Gao X
    J Control Release; 2010 Oct; 147(2):278-88. PubMed ID: 20655966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting prostate cancer cells with hybrid elastin-like polypeptide/liposome nanoparticles.
    Zhang W; Song Y; Eldi P; Guo X; Hayball JD; Garg S; Albrecht H
    Int J Nanomedicine; 2018; 13():293-305. PubMed ID: 29391790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical pharmacokinetic, biodistribution, and anti-cancer efficacy studies of a docetaxel-carboxymethylcellulose nanoparticle in mouse models.
    Ernsting MJ; Tang WL; MacCallum NW; Li SD
    Biomaterials; 2012 Feb; 33(5):1445-54. PubMed ID: 22079003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and evaluation of lipid emulsified docetaxel-loaded nanoparticles.
    Zhang F; Chang M; Yu Y; Zhang Y; Liu G; Wei T; Zuo T; Guan Y; Lin G; Zhao Z
    J Pharm Pharmacol; 2015 Nov; 67(11):1546-55. PubMed ID: 26256262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactoferrin bioconjugated solid lipid nanoparticles: a new drug delivery system for potential brain targeting.
    Singh I; Swami R; Pooja D; Jeengar MK; Khan W; Sistla R
    J Drug Target; 2016; 24(3):212-23. PubMed ID: 26219519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles.
    Hwang HY; Kim IS; Kwon IC; Kim YH
    J Control Release; 2008 May; 128(1):23-31. PubMed ID: 18374444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular cytotoxicity and in-vivo biodistribution of docetaxel poly(lactide-co-glycolide) nanoparticles.
    Esmaeili F; Dinarvand R; Ghahremani MH; Ostad SN; Esmaily H; Atyabi F
    Anticancer Drugs; 2010 Jan; 21(1):43-52. PubMed ID: 19809300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docetaxel-titanate nanotubes enhance radiosensitivity in an androgen-independent prostate cancer model.
    Mirjolet C; Boudon J; Loiseau A; Chevrier S; Boidot R; Oudot A; Collin B; Martin E; Joy PA; Millot N; Créhange G
    Int J Nanomedicine; 2017; 12():6357-6364. PubMed ID: 28919739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pluronic F-127 Stabilised Docetaxel Nanocrystals Improve Apoptosis by Mitochondrial Depolarization in Breast Cancer Cells: Pharmacokinetics and Toxicity Assessment.
    Pawar VK; Gupta S; Singh Y; Meher JG; Sharma K; Singh P; Gupta A; Bora HK; Chaurasia M; Chourasia MK
    J Biomed Nanotechnol; 2015 Oct; 11(10):1747-63. PubMed ID: 26502638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour microenvironment-responsive lipoic acid nanoparticles for targeted delivery of docetaxel to lung cancer.
    Gu F; Hu C; Tai Z; Yao C; Tian J; Zhang L; Xia Q; Gong C; Gao Y; Gao S
    Sci Rep; 2016 Nov; 6():36281. PubMed ID: 27805051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two kinds of docetaxel-vitamin E prodrugs: In vitro evaluation and in vivo antitumor activity.
    Wang J; Xue P; Zhou J; Li L; Xu L; Wang Y
    Int J Pharm; 2016 May; 505(1-2):352-60. PubMed ID: 27085643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.